 |
1AGB |
ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGRKKYKL-3R MUTATION) |
C |
A |
MHC antigen-recognition domain |
|
 |
1AGC |
ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYQL-7Q MUTATION) |
C |
A |
MHC antigen-recognition domain |
|
 |
1AGD |
ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYKL-INDEX PEPTIDE) |
C |
A |
MHC antigen-recognition domain |
|
 |
1AGE |
ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYRL-7R MUTATION) |
C |
A |
MHC antigen-recognition domain |
|
 |
1AGF |
ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKRYKL-5R MUTATION) |
C |
A |
MHC antigen-recognition domain |
|
 |
1M05 |
HLA B8 in complex with an Epstein Barr Virus determinant |
E |
A |
MHC antigen-recognition domain |
|
 |
1MI5 |
The crystal structure of LC13 TcR in complex with HLAB8-EBV peptide complex |
C |
DEA |
Immunoglobulin-like beta-sandwich |
|